A Pilot Randomized Clinical Trial of Intranasal Oxytocin to Promote Weight Loss in Individuals With Hypothalamic Obesity

CONTEXT: Hypothalamic obesity is a rare, treatment-resistant form of obesity. In preliminary studies, the hypothalamic hormone oxytocin (OXT) has shown promise as a potential weight loss therapy. OBJECTIVE: To determine whether 8 weeks of intranasal OXT (vs 8 weeks of placebo) promotes weight loss i...

Descripción completa

Detalles Bibliográficos
Autores principales: McCormack, Shana E, Wang, Zi, Wade, Kristin L, Dedio, Anna, Cilenti, Nicolette, Crowley, Julia, Plessow, Franziska, Bamba, Vaneeta, Roizen, Jeffrey D, Jiang, Yaoguang, Stylli, Jack, Ramakrishnan, Arjun, Platt, Michael L, Shekdar, Karuna, Fisher, Michael J, Vetter, Victoria L, Hocking, Matthew, Xiao, Rui, Lawson, Elizabeth A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154909/
https://www.ncbi.nlm.nih.gov/pubmed/37153702
http://dx.doi.org/10.1210/jendso/bvad037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154909/
https://www.ncbi.nlm.nih.gov/pubmed/37153702
http://dx.doi.org/10.1210/jendso/bvad037

Ejemplares similares